Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
149.22
+1.18 (0.80%)
At close: Dec 5, 2025, 4:00 PM EST
150.80
+1.58 (1.06%)
After-hours: Dec 5, 2025, 6:19 PM EST
Axsome Therapeutics Employees
Axsome Therapeutics had 683 employees as of December 31, 2024. The number of employees increased by 138 or 25.32% compared to the previous year.
Employees
683
Change (1Y)
138
Growth (1Y)
25.32%
Revenue / Employee
$821,761
Profits / Employee
-$336,057
Market Cap
7.52B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AXSM News
- 1 day ago - Axsome Therapeutics, Inc. (AXSM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 days ago - 2 Under-the-Radar Stocks to Buy Heading Into 2026 - The Motley Fool
- 15 days ago - Axsome Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - 2 Monster Stocks in the Making - The Motley Fool
- 4 weeks ago - Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy - GlobeNewsWire
- 4 weeks ago - Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics - GlobeNewsWire
- 4 weeks ago - Axsome: Alzheimer's Disease Agitation sNDA Adds Optionality, Not A Thesis Changer - Seeking Alpha
- 4 weeks ago - Axsome Therapeutics, Inc. (AXSM) Q3 2025 Earnings Call Transcript - Seeking Alpha